Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment

Fig. 2

A PL-MSCs’ morphology under the inverted microscope with phase contrast, B CD markers expression pattern (the dotted black lines are isotype controls and the orange lines are the CD markers, C Differentiation of PL-MSCs into osteocytes (Alizarin Red staining) and adipocytes (Oil Red O staining), D results of karyotyping

Back to article page